Saturday, September 13, 2025
HomeIndustriesHealthcare

Healthcare

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated...

IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...

Capital Health Performs First Watchman Implant

Physicians and staff from Capital Health's Heart and Vascular Institute recently performed their first Watchman implant procedure at Capital Health Regional Medical Center in...

Microsoft and CueZen Partner to Deliver Personalized Health Recommendations at Massive Scale

CueZen, a personalization engine for health, will be working with Microsoft Azure Health Data Services to revolutionize the healthcare industry. The collaboration aims to...

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients

Tubulis and Bristol Myers Squibb announced that they have entered into a strategic license agreement to develop differentiated antibody-drug conjugates (ADCs). Through the license agreement, Bristol Myers...

22 Provider Flagstaff Surgical Associates Transitions to eClinicalWorks V12 and Reports Significant Growth and Value

eClinicalWorks, the largest ambulatory cloud EHR, announced that Flagstaff Surgical Associates — a 22-provider practice in Flagstaff, Arizona — upgraded to eClinicalWorks’ latest software...
0FansLike
0FollowersFollow
spot_img

Hot Topics